Ameliorative effect of Abeliophyllum distichum Nakai on benign prostatic hyperplasia in vitro and in vivo

키워드

참고문헌 (50)

1. Khoury CK, "Increasing homogeneity in global food supplies and the implications for food security", Proc Natl Acad Sci U S A, 111, pp.4001~4006 (2014)
2. Sheehy CM, "Dehydration : biological considerations, age-related changes, and risk factors in older adults", Biol Res Nurs, 1, pp.30~37 (1999)
3. Agarwal A, "What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women", Eur Urol, 65, pp.1211~1217 (2014)
4. Mustonen S, "Long-term renal dysfunction in patients with acute urinary retention", Scand J Urol Nephrol, 35, pp.44~48 (2001)
5. Nicholson TM, "Androgens and estrogens in benign prostatic hyperplasia : past, present and future", Differentiation, 82, pp.184~199 (2011)
6. Vignozzi L, "Benign prostatic hyperplasia : a new metabolic disease?", J Endocrinol Invest, 37, pp.313~322 (2014)
7. Krieg M, "Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol, and estrone in epithelium and stroma of normal and hyperplastic human prostate", J Clin Endocrinol Metab, 77, pp.375~381 (1993)
8. Andriole G, "Dihydrotestosterone and the prostate : the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia", J Urol, 172, pp.1399~1403 (2004)
9. Luke MC, "Human androgen receptor binding to the androgen response element of prostate specific antigen", J Androl, 15, pp.41~51 (1994)
10. Culig Z, "Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor", Cancer Res, 54, pp.5474~5478 (1994)
11. Liu RF, "Roles of autophagy in androgen-induced benign prostatic hyperplasia in castrated rats", Exp Ther Med, 15, pp.2703~2710 (2018)
12. Baldin V, "Cyclin D1 is a nuclear protein required for cell cycle progression in G1", Genes Dev, 7, pp.812~821 (1993)
13. Waga S, "The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA", Nature, 369, pp.574~578 (1994)
14. Martinou JC, "Mitochondria in apoptosis : Bcl-2 family members and mitochondrial dynamics", Dev Cell, 21, pp.92~101 (2011)
15. Marzo I, "Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis", Science, 281, pp.2027~2031 (1998)
16. Hsu YT, "Cytosol-to-membrane redistribution of Bax and Bcl-XL during apoptosis", Proc Natl Acad Sci U S A, 94, pp.3668~3672 (1997)
17. Pirozzi L, "Current pharmacological treatment for male LUTS due to BPH : dutasteride or finasteride?", Curr Drug Targets, 16, pp.1165~1171 (2015)
18. de la Rosette JJ, "EAU guidelines on benign prostatic hyperplasia(BPH)", Eur Urol, 40, pp.256~263 (2001)
19. Lepor H, "Alpha blockers for the treatment of benign prostatic hyperplasia", Rev Urol, 9, pp.181~190 (2007)
20. Aggarwal S, "An overview on 5α-reductase inhibitors", Steroids, 75, pp.109~153 (2010)
21. Traish AM, "Adverse side effects of 5α-reductase inhibitors therapy : persistent diminished libido and erectile dysfunction and depression in a subset of patients", J Sex Med, 8, pp.872~884 (2011)
22. Steenkamp V, "Studies on antibacterial, anti-inflammatory and antioxidant activity of herbal remedies used in the treatment of benign prostatic hyperplasia and prostatitis", J Ethnopharmacol, 103, pp.71~75 (2006)
23. Lee TB, "Studies on conservation of endemic species Abeliophyllum distichum", J Nat Conserv, 12, pp.6~10 (1976)
24. 유주한, "미선나무 자생지 주변의 초본군락과 식물상 분석", 한국자원식물학회지, 18(2), pp.315~13 (2005), 한국자원식물학회
25. 권순복, "미선나무 잎과 줄기의 성분 분석 및 안전성 평가", 한국환경보건학회지, 40(3), pp.234~244 (2014), 한국환경보건학회[DOI]
26. 장성준, "건조방법에 따른 미선나무 잎의 항산화 및 항염증 효과", Food Science and Preservation, 25(1), pp.27~35 (2018), 한국식품저장유통학회
27. Kim EY, "Abeliophyllum distichum Nakai alleviates postmenopausal osteoporosis in ovariectomized rats and prevents RANKL-induced osteoclastogenesis in vitro", J Ethnopharmacol, 257, pp.112828~ (2020)
28. Park GH, "The induction of activating transcription factor 3(ATF3)contributes to anti-cancer activity of Abeliophyllum distichum Nakai in human colorectal cancer cells", BMC Complement Altern Med, 14, pp.487~ (2014)
29. Yoo TK, "Polyphenolic composition and anti-melanoma activity of white forsythia(Abeliophyllum distichum nakai)organ extracts", Plants(Basel), 9, pp.757~ (2020)
30. 안정좌, "Effects of Abeliophyllum distichum Nakai Flower Extracts on Antioxidative Activities and Inhibition of DNA Damage", 한국자원식물학회지, 26(3), pp.355~361 (2013), 한국자원식물학회[DOI]
31. Kim HW, "Verbascoside-rich Abeliophyllum distichum Nakai leaf extracts prevent LPS-induced preterm birth through inhibiting the expression of proinflammatory cytokines from macrophages and the cell death of trophoblasts induced by TNF-α", Molecules, 25, pp.4579~ (2020)
32. Eom J, "Abeliophyllum distichum ameliorates high-fat diet-induced obesity in C57BL", 6J mice by upregulating the AMPK pathway, 2020, pp.12, 3320~
33. Bent S, "Saw palmetto for benign prostatic hyperplasia", N Engl J Med, 354, pp.557~566 (2006)
34. Marks LS, "Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia", J Urol, 163, pp.1451~1456 (2000)
35. Choi YJ, "Metabolomic analysis of Morus cultivar root extracts and their ameliorative effect on testosterone-induced prostate enlargement in Sprague-Dawley rats", Int J Mol Sci, 21, pp.1435~ (2020)
36. Cunha GR, "Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors", J Androl, 13, pp.465~475 (1992)
37. Grino PB, "Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone", Endocrinology, 126, pp.1165~1172 (1990)
38. Ueda T, "Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells", J Biol Chem, 277, pp.38087~38094 (2002)
39. Nandeesha H, "Benign prostatic hyperplasia : dietary and metabolic risk factors", Int Urol Nephrol, 40, pp.649~656 (2008)
40. McVary KT, "A review of combination therapy in patients with benign prostatic hyperplasia", Clin Ther, 29, pp.387~398 (2007)
41. Miao MS, "Effects of total flavonoids from bastard speedwell on benign prostatic hyperplasia rats models", Chin J Mod Appl Pharm, 28, pp.4~7 (2011)
42. Dai GC, "Chemical characterization, anti-benign prostatic hyperplasia effect and subchronic toxicity study of total flavonoid extract of Pteris multifida", Food Chem Toxicol, 108, pp.524~531 (2017)
43. Jean-Francois Bisson, "Therapeutic Effect of ACTICOA Powder, a Cocoa Polyphenolic Extract, on Experimentally Induced Prostate Hyperplasia in Wistar-Unilever Rats", Journal of Medicinal Food, 10(4), pp.628~635 (2007), 한국식품영양과학회
44. Wu Y, "The antiandrogenic effect of finasteride against a mutant androgen receptor", Cancer Biol Ther, 11, pp.902~909 (2011)
45. Carson C 3rd, "The role of dihydrotestosterone in benign prostatic hyperplasia", Urology, 61, pp.2~7 (2003)
46. Vickman RE, "The role of the androgen receptor in prostate development and benign prostatic hyperplasia : a review", Asian J Urol, 7, pp.191~202 (2020)
47. Olaisen C, "PCNA-interacting peptides reduce Akt phosphorylation and TLR-mediated cytokine secretion suggesting a role of PCNA in cellular signaling", Cell Signal, 27, pp.1478~1487 (2015)
48. Li Z, "Leptin induces cyclin D1 expression and proliferation of human nucleus pulposus cells via JAK", STAT, PI3K, ERK pathways, pp.PLoS One, 2012[DOI]
49. Khalaf HA, "Verbascoside—A review of its antitumor activities", Pharmacol Pharm, 12, pp.109~126 (2021)
50. Huang Y, "Inhibition effects of chlorogenic acid on benign prostatic hyperplasia in mice", Eur J Pharmacol, 809, pp.191~195 (2017)

관련 논문AI추천